Tag Archive for: BaseLaunch

BaseLaunch announces a new partnership with AbbVie

Media release Basel, Switzerland, 22.05.2024 BaseLaunch announces a new partnership with AbbVie Further strengthens BaseLaunch’s global pharma industry partnerships 24 early-stage biotech ventures have now been supported by BaseLaunch Portfolio companies have raised over US$ 600 million in equity capital BaseLaunch, the Basel-based biotech venture incubator, today announces that AbbVie has become its newest partner. […]

Engimmune Therapeutics raises CHF 15.5 million in seed financing to develop novel T-cell receptor therapeutics

Financing co-led by Pureos Bioventures and Novo Holdings with incubation from BaseLaunch Proceeds will be used to develop next-generation T-cell receptor-based therapies for cancer treatment TCR therapy pioneer and industry veteran Dr Bent Jakobsen appointed as Chairman of the Board Basel, Switzerland, May 3, 2022. Engimmune Therapeutics AG (“Engimmune”), a Swiss biotech company developing novel […]

Applications for BaseLaunch Phase II accelerator program to close on 22nd June

This is a fantastic initiative that helps young businesses by providing the support they need to succeed. This includes up to USD 500,000 in fundraising, introduction to a dynamic network and access to free lab space.